Drug Pipeline

Meningococcal Group B Vaccine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06832514 Investigating Gender and Sex Differences in Immune Responses Through Vaccination of… Meningococcal Meningitis, Serogroup B Recruiting
Phase 2
NCT04350138 Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to… Gonococcal Infection Active, Not Recruiting
Phase 1/2
NCT06647407 Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine… Meningococcal Immunization Active, Not Recruiting
Sponsors Running Meningococcal Group B Vaccine Trials
National Institute of Allergy and Infectious Diseases (NIAID) (1) Sanofi Pasteur, a Sanofi Company (1) University Ghent (1)
Get alerts when Meningococcal Group B Vaccine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free